Table 2 List of the treatments in patients with malignant chylothorax
From: Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders
Patient | Chemotherapy | Low-fat diet | Parenteral nutrition | RT | Chylothorax treatment duration (days) |
|---|---|---|---|---|---|
1. | FCR | yes | yes | no | 82 |
2. | FCR, R-Dex | yes | yes | no | 87 |
3. | FCR, RCD, R-CHOP | yes | yes | yes | 125 |
4. | FCR | no | no | no | 18 |
5. | obinutuzumab+bendamustine | no | yes | no | 25 |
6. | obinutuzumab+bendamustine | yes | yes | no | 82 |
7. | FCR | yes | yes | yes | 69 |
8. | R-CHOP | yes | yes | no | 58 |
9. | R-CHOP/R-megaCHOP, R-ESHAP/R-GDP, 2x ASCT | yes | yes | no | 35 |
10. | GDP | no | no | no | 77 |